Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
263K
-
Shares change
-
+474
-
Total reported value, excl. options
-
$1.96M
-
Value change
-
+$6.4K
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$7.43
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2018
23 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q2 2018.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 263K shares
of 41M outstanding shares and own 0.64% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (53.1K shares), BARCLAYS PLC (41.2K shares), MORGAN STANLEY (29.3K shares), BlackRock Inc. (28K shares), PNC Financial Services Group, Inc. (21.2K shares), GLENMEDE TRUST CO NA (20K shares), DEUTSCHE BANK AG\ (17.6K shares), Rossmore Private Capital (15.1K shares), WELLS FARGO & COMPANY/MN (10.7K shares), and UBS Group AG (8.17K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.